Sitemap xml

Ashraf S, et al. Trials. 2021 Sep 6;22(1):591. doi: 10.1186/s13063-021-05487-z. Trials. 2021. PMID: 34488858 . Mt Sinai J Med. 2002 May;69(3):148-55. Mt Sinai J Med. 2002. PMID: 12035074 Review. .

Cite .

Cite .

Cite .

Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study protocol for a randomised controlled trial.

Ashraf S, Ashraf S, Farooq I, Ashraf S, Ashraf M, Imran MA, Kalsoom L, Akmal R, Ghufran M, Rafique S, Akram MK, Habib Z, Siddiqui UN, Ahmad A, Arshad S, Virk MAR, Gul M, Awais AB, Hassan M, Sherazi SSH, Safdar Z, Munir I, Khalid H, Munir K, Majeed N, Alahmadi YM, Humayun A, Saboor QA, Ahmad A, Ashraf M, Izhar M; DOCTORS LOUNGE Consortium. .

Cite .

507 .

Cite

Page

Menu

News

Page

Menu

News

• Gluten intolerance a significant risk factor
• Infectious disease of the uterus
• Absence of an individual specific disease

 

Page

Menu

News